Monday, August 19, 2019
Home WuXi News Volume #001 - June 2019

Volume #001 - June 2019

The Game-Changing Potential of Targeting RNA with Small Molecules: More Than Turning the Undruggable...

By Rich Soll, Senior Advisor, Strategic Initiatives, WuXi AppTec (@richsollwx) Once considered impossible, targeting RNA with small molecules has the potential to be a game-changer. It’s convincing enough to industry veteran Michael...

WuXi AppTec Acquires Pharmapace to Enhance Biometrics Services for Clinical Development

Shanghai, China & San Diego, California May 6, 2019 - WuXi AppTec, a leading global pharmaceutical and medical device open-access capability and technology platform company, today announced that it has acquired...

SUBSCRIBE TO OUR NEWSLETTER

SPOTLIGHT

STAY CONNECTED

Twitter LinkedIn 

WUXI NEWS

WuXi STA Shanghai & Changzhou Facilities Pass U.S. FDA Inspections

SHANGHAI, 24 July, 2019: STA Pharmaceutical Co., Ltd., (WuXi STA) – a subsidiary of WuXi AppTec – announces that its Analytical Service Unit (ASU) in...